Thomas Amatruda

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio et al. · Journal of Clinical Oncology · 2015 · 2.5K citations · Full text

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

Neil Senzer, Howard L. Kaufman, Thomas Amatruda et al. · Journal of Clinical Oncology · 2009 · 607 citations · Full text

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

Robert H.I. Andtbacka, Merrick Ross, Igor Puzanov et al. · Annals of Surgical Oncology · 2016 · 295 citations · Full text

G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells.

Thomas Amatruda, David A. Steele, Vladlen Z. Slepak et al. · Proceedings of the National Academy of Sciences · 1991 · 264 citations · Full text

Immunology, Blood Cell, Antigen Processing +16

Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.

Koeffler Hp, Thomas Amatruda, N. IKEKAWA et al. · PubMed · 1984 · 230 citations

Inflammation, Hematological Malignancy, 1,25-Dihydroxyvitamin D3 +15